LongBio Pharma Amends Bylaws to Reflect Share Capital Changes After Full Overallotment Exercise
PUBT · 1d ago
Share
Listen to the news
- LongBio Pharma shareholders approved bylaw amendments at an extraordinary general meeting on October 30, 2026.
- Amendments to Articles 3, 6 and 20 reflect registered share capital and capital structure changes following full exercise of the over-allotment option.
- Changes to Article 69 align the bylaws more closely with applicable domestic laws and regulations.
- Both resolutions passed with 99.99% support.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longbio Pharma (Suzhou) Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261030-12391457), on October 30, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending